Healthcare providers increasingly encounter patients using cannabis therapeutically or recreationally, creating complex scenarios where disclosure obligations, confidentiality protections, and clinical risk assessment intersect. These ethical and legal tensions directly impact patient trust, treatment outcomes, and provider liability in states with varying cannabis laws.
This analysis examines the intersection of patient confidentiality, mandatory reporting requirements, and cannabis use disclosure in clinical settings. Healthcare providers face competing obligations when patients report cannabis use that may impact safety-sensitive activities or when disclosure could trigger legal consequences. The ethical framework must balance patient autonomy, clinical duty to warn, and evolving legal landscapes across jurisdictions with different cannabis policies.
“I regularly navigate these exact scenarios — patients need to trust they can discuss cannabis use openly for optimal care, but providers need clear guidance on when confidentiality has limits. The current patchwork of laws creates unnecessary clinical complexity that ultimately serves no one well.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
<!– {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Ethical and Legal Dilemmas in Risk Assessment and Confidentiality: Cannabis Use …”, “url”: “https://www.scirp.org/journal/paperinformation?paperid=150079”, “datePublished”: “2026-03-12T10:00:15Z”, “about”: “ethical legal dilemmas risk assessment confidentiality”} –>
Get the next evidence review in your inbox
Plain-language summaries of the newest cannabis research, written by a physician. Free to read, and you can unsubscribe at any time.
Join the growing cannabis community. Free. One-click subscribe. Delivered by Substack.
